Is it safe to proceed with colon resection tomorrow in a 91-year-old female with a newly diagnosed colon mass and newly identified bilateral segmental and subsegmental pulmonary emboli?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Delay Surgery Until PE is Therapeutically Anticoagulated

Surgery tomorrow is NOT safe and should be postponed. This 91-year-old patient has acute bilateral segmental and subsegmental pulmonary emboli with clot extending into the distal main pulmonary arteries—this represents intermediate-risk PE that requires stabilization before elective surgery 1.

Risk Stratification of the Pulmonary Embolism

The imaging findings are concerning:

  • Bilateral segmental and subsegmental PE with distal main PA involvement
  • Prominent occlusion of basilar right lower lobe branches
  • Likely pulmonary infarct (groundglass opacity with interstitial thickening in RLL)
  • No right heart strain on CT (favorable finding)

According to ESC guidelines, this patient falls into the intermediate-risk category 1. While there's no hemodynamic instability (which would make this high-risk), the burden of clot is substantial with evidence of pulmonary infarction. The absence of CT evidence of right heart strain is reassuring but doesn't eliminate perioperative risk.

Why Surgery Must Be Delayed

Immediate Perioperative Risks:

  1. Catastrophic intraoperative PE: Major surgery with general anesthesia, pneumoperitoneum (if laparoscopic), and hemodynamic shifts can dislodge existing thrombus or propagate clot, leading to massive PE 2. The case literature documents fatal intraoperative PE even in optimized patients.

  2. Hemorrhagic complications: The patient will require therapeutic anticoagulation for PE, which directly conflicts with major abdominal surgery and creates unacceptable bleeding risk during colonic resection.

  3. Emergency surgery mortality in elderly: While elective surgery in nonagenarians with colorectal cancer shows reasonable outcomes (in-hospital mortality 6.25%), emergency surgery mortality jumps to 42.9% 3. Converting tomorrow's "elective" case into an urgent/semi-emergent procedure by operating on unstable PE increases mortality risk substantially.

Recommended Management Algorithm

Phase 1: Stabilize the PE (Days 1-7)

  • Initiate therapeutic anticoagulation immediately with LMWH or unfractionated heparin (avoid DOACs given impending surgery)
  • Monitor for hemodynamic deterioration
  • Assess for right heart strain with echocardiography if not already done
  • Calculate PESI or sPESI score to confirm risk stratification 1

Phase 2: Reassess Surgical Candidacy (Week 2-4)

  • Minimum 7-14 days of therapeutic anticoagulation before reconsidering surgery
  • Repeat imaging to assess clot burden and resolution
  • Ensure hemodynamic stability
  • Consider IVC filter placement if anticoagulation must be interrupted perioperatively (though this adds its own risks)

Phase 3: Perioperative PE Management

When surgery is rescheduled:

  • Extended thromboprophylaxis for 28 days postoperatively is mandatory for colorectal cancer 4
  • Use mechanical prophylaxis (compression stockings + intermittent pneumatic compression) 4
  • Bridge anticoagulation carefully: stop LMWH 24 hours preoperatively, resume 12-24 hours postoperatively if hemostasis adequate
  • Consider epidural anesthesia cautiously given anticoagulation requirements 4

Special Considerations for This 91-Year-Old Patient

Age alone is not a contraindication to surgery 3, 5. The study of nonagenarians with colorectal cancer showed surgical treatment provided significantly longer survival (median 23.92 months) versus non-operative management (2.99 months) 3. However, this survival benefit assumes elective, optimized surgery—not rushing into the OR with acute PE.

Critical Pitfall to Avoid:

The PE may have been present before diagnosis 6. Studies show 4.7% of colorectal cancer patients have asymptomatic PE on staging CT, with 8.3% in stage IV disease. This doesn't change management but reinforces that the PE isn't necessarily "new" and the cancer isn't acutely progressing during the delay.

Addressing the Colon Mass

While delaying surgery for a colon mass is never ideal, a 2-3 week delay for PE stabilization is justified and unlikely to significantly alter oncologic outcomes compared to the catastrophic risk of intraoperative massive PE or major hemorrhage. The mass appears to be for resection (not described as obstructing or perforated based on the clinical scenario), making this truly elective.

If the patient develops obstruction or perforation during PE treatment, this becomes a different risk-benefit calculation requiring multidisciplinary discussion about IVC filter placement and accepting higher surgical risk.


Bottom line: Postpone surgery for minimum 7-14 days while therapeutically anticoagulating the PE. Reassess with repeat imaging and clinical stability before proceeding with optimized elective surgery.

Related Questions

How should I manage vomiting in an 11-month-old infant?
How should I evaluate and manage a patient with a blood pressure of 122/77 mm Hg and a heart rate of 123 beats per minute (tachycardia)?
In a 13‑day‑old infant presenting with fever and poor feeding, what interventions should emergency medical services (EMS) perform?
Should a 13-year-old patient requesting breast augmentation undergo the procedure, and what is the appropriate management if it should not be performed?
How should a 10-year-old child presenting with cough and wheeze be evaluated and managed?
For a 68-year-old man with intermediate‑unfavourable prostate adenocarcinoma (ISUP grade 3, PSA 12 ng/mL, clinical stage cT2b, MRI without nodal involvement), what phase III trial evidence compares five‑fraction stereotactic body radiotherapy (SBRT) with moderate hypofractionation regarding biochemical control and late genitourinary toxicity, including trial names, sample sizes, and median follow‑up, and does the evidence appear limited?
What is the likely cause and recommended management for a 34‑year‑old woman with controlled type 2 diabetes mellitus on empagliflozin (Jardiance), metformin, and levothyroxine (Synthroid) who has had five days of swelling, pain, and redness of the labia and clitoris unresponsive to topical clobetasol?
What are the appropriate breast cancer screening and risk‑reduction recommendations for a 27‑year‑old woman whose only risk factor is a first‑degree relative diagnosed with triple‑negative breast cancer at age 60?
Can I use brexpiprazole (Rexulti) 0.5 mg with amphetamine/dextroamphetamine (Adderall) 20 mg, buspirone (Buspar) 7.5 mg, duloxetine delayed‑release 60 mg, topiramate 100 mg, doxazosin 4 mg, and spironolactone to treat anxiety and post‑traumatic stress disorder?
In a woman taking empagliflozin (SGLT2 inhibitor), metformin, and levothyroxine who began fluconazole yesterday on an every‑other‑day regimen and now has a markedly enlarged, painful clitoris, how should this be managed?
Will a fishbone lodged in the throat appear on a plain X‑ray?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.